Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis

European Journal of Immunology

Volumn 41, Issue 9, 2011, Pages 2774-2781

  Rahnefeld, Anna ^a   Ebstein, Frédéric ^a   Albrecht, Nadine ^a   Opitz, Elisa ^a   Kuckelkorn, Ulrike ^a   Stangl, Karl ^a   Rehm, Armin ^b   Kloetzel, Peter M ^a   Voigt, Antje ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Animal models; DC; Infectious disease; Myocarditis; Proteasome; Virology

Indexed keywords

ALPHA ACTIN; ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12P40; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; COXSACKIE VIRUS B3; CROSS PRESENTATION; DENDRITIC CELL; ENTEROVIRUS; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RIBOSOME; UBIQUITINATION; VIRUS IMMUNITY; VIRUS MYOCARDITIS; VIRUS RESISTANCE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; CROSS-PRIMING; CYTOKINES; DENDRITIC CELLS; ENTEROVIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDITIS; UBIQUITINATION; VIRULENCE;

EID: 80052181617     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041039     Document Type: Article

References (31)

1. Selinka, H. C., Wolde, A., Sauter, M., Kandolf, R., and Klingel, K., Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med. Microbiol. Immunol. 2004. 193: 127-131.
2. Wessely, R., Klingel, K., Santana, L. F., Dalton, N., Hongo, M., Lederer, W. J., Kandolf, R. et al., Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 1998. 102: 1444-1453.
3. Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., Mall, G., and Kandolf, R., Ongoing enterovirus-induced myocarditis is associated with persistent heart-muscle infection - quantitative-analysis of virus-replication, tissue-damage, and inflammation. Proc. Natl. Acad. Sci. USA 1992. 89: 314-318.
4. Jakel, S., Kuckelkorn, U., Szalay, G., Plotz, M., Textoris-Taube, K., Opitz, E., Klingel, K. et al., Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am. J. Pathol. 2009. 175: 510-518.
5. Klingel, K., Stephan, S., Sauter, M., Zell, R., McManus, B. M., Bultmann, B., and Kandolf, R., Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J. Virol. 1996. 70: 8888-8895.
6. Klingel, K., Schnorr, J. J., Sauter, M., Szalay, G., and Kandolf, R., beta 2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am. J. Pathol. 2003. 162: 1709-1720.
7. Szalay, G., Meiners, S., Voigt, A., Lauber, J., Spieth, C., Speer, N., Sauter, M. et al., Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am. J. Pathol. 2006. 168: 1542-1552.
8. Deonarain, R., Cerullo, D., Fuse, K., Liu, P. P., and Fish, E. N., Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004. 110: 3540-3543.
9. Wessely, R., Klingel, K., Knowlton, K.U., and Kandolf, R., Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling - implications for mortality and early viral replication. Circulation 2001. 103: 756-761.
10. Melief, C. J. M., Cancer immunotherapy by dendritic cells. Immunity 2008. 29: 372-383.
11. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., and Melief, C. J. M., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
12. Kawai, T. and Akira, S., Innate immune recognition of viral infection. Nat. Immunol. 2006. 7: 131-137.
13. Schuurhuis, D. H., Laban, S., Toes, R. E. M., Ricciardi-Castagnoli, P., Kleijmeer, M. J., van der Voort, E. I. H., Rea, D. et al., Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 2000. 192: 145-150.
14. Steinman, R. M. and Banchereau, J., Taking dendritic cells into medicine. Nature 2007. 449: 419-426.
15. Burgdorf, S., Scholz, C., Kautz, A., Tampe, R., and Kurts, C., Spatial separation of cross-presentation and endogenous antigen presentation. Wiener Klinische Wochenschrift 2008. 120: 36.
16. Kurts, C., Robinson, B. W. S., and Knolle, P. A., Cross-priming in health and disease. Nat. Rev. Immunol. 2010. 10: 403-414.
17. Kloetzel, P. M., Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2001. 2: 179-187.
18. Glickman, M. H. and Ciechanover, A., The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 2002. 82: 373-428.
19. Liu, Y. C., Penninger, J., and Karin, M., Immunity by ubiquitylation: A reversible process of modification. Nat. Rev. Immunology 2005. 5: 941-952.
20. Dalod, M., Hamilton, T., Salomon, R., Salazar-Mather, T. P., Henry, S.C., Hamilton, J. D., and Biron, C.A., Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003. 197: 885-898.
21. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P., and Steinman, R. M., HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 2004. 101: 7669-7674.
22. Zimmermann, M., Flechsig, C., La Monica, N., Tripodi, M., Adler, G., and Dikopoulos, N., Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J. Hepatol. 2008. 48: 51-60.
23. Krausslich, H. G., Nicklin, M. J. H., Toyoda, H., Etchison, D., and Wimmer, E., Poliovirus proteinase-2A induces cleavage of eukaryotic initiation factor-4F polypeptide-P220. J. Virol. 1987. 61: 2711-2718.
24. Gradi, A., Svitkin, Y. V., Imataka, H., and Sonenberg, N., Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl. Acad. Sci. USA 1998. 95: 11089-11094.
25. Gabriele, L. and Ozato, K., The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 2007. 18: 503-510.
26. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., and Bennink, J. R., Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000. 404: 770-774.
27. Reits, E. A. J., Vos, J. C., Gromme, M., and Neefjes, J., The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000. 404: 774-778.
28. Lelouard, H., Ferrand, V., Marguet, D., Bania, J., Camosseto, V., David, A., Gatti, E. et al., Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J. Cell Biol. 2004. 164: 667-675.
29. Herter, S., Osterloh, P., Hilf, N., Rechtsteiner, G., Hohfeld, J., Rammensee, H. G., and Schild, H., Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells. J. Immunol. 2005. 175: 891-898.
30. Ebstein, F., Lange, N., Urban, S., Seifert, U., Kruger, E., and Kloetzel, P. M., Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 2009. 41: 1205-1215.
31. Voigt, A., Jakel, S., Textoris-Taube, K., Keller, C., Drung, I., Szalay, G., Klingel, K. et al., Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. Amino Acids 2010. 39: 243-255.